Literature DB >> 2939007

In vitro effect of cyclosporin A on immunoglobulin production and concanavalin A induced suppression in primary biliary cirrhosis.

M N Al-Aghbar, G J Alexander, K T Nouri-Aria, J Neuberger, A L Eddleston, R Williams.   

Abstract

The in vitro effect of Cyclosporin A on the regulation of immunoglobulin production was investigated in 16 patients with primary biliary cirrhosis. A significant improvement in concanavalin A induced suppression of IgG and IgM producing cells was observed after prior incubation of mononuclear cells with 300 ng/ml Cyclosporin A for 30 minutes. No effect was seen on spontaneous or pokeweed mitogen induced immunoglobulin production, nor on con A induced suppression if Cyclosporin A was added after 24 hours. Incubation of mononuclear cells with a variable dose of Cyclosporin A showed an effect only at 250-500 ng/ml. Higher and lower doses had no effect. This dose dependent effect of Cyclosporin A is likely to be related to a differential inhibitory effect on T helper and T suppressor cells and may underlie the clinical benefit being observed in current clinical trials.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2939007      PMCID: PMC1433424          DOI: 10.1136/gut.27.3.317

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

1.  Effect of steroid therapy on the clinical and laboratory features of primary biliary cirrhosis.

Authors:  C T CARMAN; J E GIANSIRACUSA
Journal:  Gastroenterology       Date:  1955-02       Impact factor: 22.682

2.  Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells.

Authors:  D J White; A M Plumb; G Pawelec; G Brons
Journal:  Transplantation       Date:  1979-01       Impact factor: 4.939

3.  Lymphocyte subsets and integrated immune function in aging humans.

Authors:  H M Hallgren; J H Kersey; D P Dubey; E J Yunis
Journal:  Clin Immunol Immunopathol       Date:  1978-05

4.  Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis.

Authors:  S P James; C O Elson; E A Jones; W Strober
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

5.  Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

6.  Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.

Authors:  A D Hess; P J Tutschka
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

7.  Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

Authors:  R Y Calne; K Rolles; D J White; S Thiru; D B Evans; P McMaster; D C Dunn; G N Craddock; R G Henderson; S Aziz; P Lewis
Journal:  Lancet       Date:  1979-11-17       Impact factor: 79.321

8.  The late results of long-term treatment of primary biliary cirrhosis by corticosteroids.

Authors:  H T Howat; A J Ralston; H Varley; J A Wilson
Journal:  Rev Int Hepatol       Date:  1966

9.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

10.  Selective effects of cyclosporin A on functional B cell subsets in the mouse.

Authors:  A Kunkl; G G Klaus
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

View more
  1 in total

Review 1.  Primary biliary cirrhosis.

Authors:  J Neuberger; M Lombard; R Galbraith
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.